Riggs Josh 4
4 · Oncocyte Corp · Filed Feb 28, 2023
Insider Transaction Report
Form 4
Riggs Josh
CEO and President
Transactions
- Award
Option to Purchase Common Stock
2023-02-24+116,426→ 116,426 totalExercise: $0.39Exp: 2033-02-24→ Common Stock (116,426 underlying)
Footnotes (1)
- [F1]One third of the options will become exercisable after one year of continuous service from the effective date of grant, and the balance will become exercisable in 24 equal monthly installments commencing one year after the date of grant subject to continuous service through the applicable vesting date.